- Home
- CRNT vs LYEL Comparison
CRNT vs LYEL Comparison
Compare CRNT & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- LYEL
- Stock Information
- Founded
- CRNT 1996
- LYEL 2018
- Country
- CRNT Israel
- LYEL United States
- Employees
- CRNT N/A
- LYEL N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- LYEL Health Care
- Exchange
- CRNT Nasdaq
- LYEL Nasdaq
- Market Cap
- CRNT 218.8M
- LYEL 207.7M
- IPO Year
- CRNT 2000
- LYEL 2021
- Fundamental
- Price
- CRNT $2.02
- LYEL $11.08
- Analyst Decision
- CRNT Strong Buy
- LYEL Sell
- Analyst Count
- CRNT 4
- LYEL 2
- Target Price
- CRNT $5.50
- LYEL $15.00
- AVG Volume (30 Days)
- CRNT 966.7K
- LYEL 29.6K
- Earning Date
- CRNT 08-06-2025
- LYEL 08-12-2025
- Dividend Yield
- CRNT N/A
- LYEL N/A
- EPS Growth
- CRNT 34.68
- LYEL N/A
- EPS
- CRNT 0.15
- LYEL N/A
- Revenue
- CRNT $380,518,000.00
- LYEL $60,000.00
- Revenue This Year
- CRNT N/A
- LYEL N/A
- Revenue Next Year
- CRNT $7.19
- LYEL N/A
- P/E Ratio
- CRNT $13.59
- LYEL N/A
- Revenue Growth
- CRNT 5.06
- LYEL 11.11
- 52 Week Low
- CRNT $1.82
- LYEL $7.65
- 52 Week High
- CRNT $5.73
- LYEL $32.00
- Technical
- Relative Strength Index (RSI)
- CRNT 47.12
- LYEL 53.12
- Support Level
- CRNT $1.98
- LYEL $10.56
- Resistance Level
- CRNT $2.06
- LYEL $11.67
- Average True Range (ATR)
- CRNT 0.07
- LYEL 0.62
- MACD
- CRNT 0.02
- LYEL -0.01
- Stochastic Oscillator
- CRNT 85.67
- LYEL 75.31
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.